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ABSTRACT
The aim of the present study was to examine neurocognitive function associated with chronic nicotine use. A total of
2163 healthy participants (1002 smokers, 1161 never-smoking controls) participated in a population-based case-
control design. The main outcome measures were six cognitive domain factors derived from a neuropsychological test
battery. In smokers, the battery was administered after controlled smoking of one cigarette. Analyses included age, sex
and education as covariates. Results demonstrated small, but significant deficits in smokers for visual attention
(P < 0.001) and cognitive impulsivity (P < 0.006), while verbal episodic memory, verbal fluency, verbal working
memory, and Stroop-interference did not differ between groups. These attention/impulsivity deficits were also present
in smokers with only a low amount of cigarette consumption. Lifetime nicotine use (pack-years) was not correlated
with cognition in smokers. In conclusion, this study confirmed subtle and specific cognitive deficits in non-deprived
smokers. The independence of these deficits from consumption intensity may argue for an a priori deficit of some
cognitive abilities in smokers. These specific deficits may constitute intermediate phenotypes for genetic research on
nicotine use.
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INTRODUCTION
Smoking-related diseases are still a major cause of pre-
ventable early deaths. A deeper understanding of the bio-
logical and psychological factors underlying habitual
smoking and of the effects of nicotine on brain function-
ing is required to address this fundamental health
problem.
Cognitive enhancement by nicotine is likely to be a
factor relevant for the development of habitual smoking.
Smoking and nicotine administration acutely improve
aspects of cognition, in particular attention and working
memory. These cognitive enhancement effects are inde-
pendent from relief from withdrawal in smokers, and
probably contribute to the initiation and maintenance of
smoking (Newhouse, Potter & Singh 2004; Heishman,
Kleykamp & Singleton 2010).
While acute nicotine consumption confers short-term
cognitive benefits, chronic smoking is generally associ-
ated with cognitive impairments, although the data on
the amount and profile of these impairments vary widely
across studies (Durazzo, Meyerhoff & Nixon 2010). Such
an association between chronic smoking and cognitive
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smokers (or future smokers) may have some minor cog-
nitive deficits, which predispose them to start or to main-
tain smoking (e.g.Yakir et al. 2007); (2) chronic smoking
may directly cause cognitive deficits, e.g. through neuro-
toxic effects of nicotine or through vascular effects (e.g.
Swan& Lessov-Schlaggar 2007); and (3) smoking is asso-
ciatedwith psychiatric co-morbidity, and these co-morbid
conditions, rather than smoking per se, are associated
with cognitive deficits (Newhouse et al. 2004; de Leon &
Diaz 2005).
Disentangling these different causes poses method-
ological challenges. We are mainly interested in the pre-
disposing (including genetic) factors relevant for the
initiation andmaintenance of smoking. Do smokers (or a
subgroup) get to be smokers because they combat some
form of enduring attentional impairment, resulting from
genetic and other distal causes? This hypothesis is stimu-
lated by the recent discovery of cholinergic gene variants
being related both to smoking and to cognition (e.g. Win-
terer et al. 2007, 2010; Rigbi et al. 2008; Petrovsky et al.
2010). Some aspects of cognition may constitute an
endophenotype of genes also associated with smoking.
The epidemiological evidence with population-based
cohorts is limited. An epidemiological study of over
14 000middle-aged subjects (45–65 years), not screened
for psychiatric disorders (except exclusion of subjects
reporting use of antipsychotic drugs), found small deficits
[0.1–0.2 standard deviations (SDs)] in current smokers,
most consistently in visual–motor coding (Cerhan et al.
1998). Another study of 1927 randomly selectedmiddle-
aged and elderly subjects (45–70 years) found slightly
lower psychomotor speed and cognitive flexibility in
current smokers, while delayed memory was not
impaired (Kalmijn et al. 2002). In the Whitehall II study
covering a similar age range (47–67), smokers weremore
likely to have poorer memory than never-smokers, while
reasoning and fluency tasks showed no differences (Sabia
et al. 2008). These studies suggest that cognitive deficits
in smokers are rather subtle. However, psychiatric
(co-) morbidity has not been systematically excluded in
these cohorts, and the average age of these cohorts leaves
it open whether neurocognitive impairments are the
result of a toxic exposure over decades. Indeed, some
studies have reported cognitive deficits to be more pro-
nounced in heavy or long-time smokers (e.g. Cerhan et al.
1998). As elderly subjects often stop smoking because of
health concerns, elderly smokers may also not be repre-
sentative for the group of subjects who ever smoked.
Studying younger subjects can avoid such confounds.
In a population-representative sample of over 20 000
Israeli military recruits 18–21 years old, screened for the
absence of psychiatric disorders, Weiser et al. (2010)
found mild, but significant cognitive deficits (about 0.27
SD units, after controlling for socioeconomic status) in
current smokers, as compared with never-smokers.
Importantly, subjects who started smoking only after the
draft board assessment, during their term in the military,
also had significant deficits initially, excluding nicotine
withdrawal during testing as a cause, and suggesting that
subtle cognitive impairments may be a risk factor for the
initiation and maintenance of smoking. Prospective
observational data support this hypothesis: self-reported
symptoms of inattention and hyperactivity/impulsivity
during early adolescence (while all subjects were still
non-smokers) were found to predict smoking in early
adulthood (Kollins, McClernon & Fummeler 2005). Simi-
larly, adolescent childhood cancer survivors with more
attention problems were more likely to start smoking
during the next decade (Kahalley et al. 2010). These
studies suggest that observable cognitive deficits precede
the initiation of smoking, and thus may play a causal
role, rather than being a consequence of long-term
exposure.
While epidemiological studies usually employ a very
limited number of cognitive tests, Yakir et al. (2007)
described the cognitive phenotype of young smokers in
more detail. They compared 91 regularly smoking
women with 151 non-smoking controls, 46 women who
had smoked in the past but had quitted and 40 occasional
smokers with regard to their cognitive functioning. In
order to avoid effects of nicotine withdrawal, they only
included data from current smokers who reported that
they had smoked their last cigarette less than 3 hours
before completion of the test session. Subjects performed
a computerized neuropsychological test battery compris-
ing 12 tests with a total of 32 dependent variables. Both
current and previous smokers, but not occasional
smokers, significantly differed from never-smoking con-
trols in some tests of attention and impulsivity, suggest-
ing that deficits in these functions may indeed be
predisposing factors for smoking. However, it remains to
be shown whether a deficit pattern as described by Yakir
et al. (2007) would also be found in a more representa-
tive, population-based sample and with more broadly
used neuropsychological tests.
Therefore, we aimed at investigating the cognitive
profile of non-smokers and smokers in a population-
based sample within the framework of a multi-center
study on the genetics of nicotine abuse (Lindenberg et al.
2011). We hypothesized that smokers would differ from
non-smokers in their cognitive profile, and based on the
findings of Yakir et al. (2007), we hypothesized that
smokers would exhibit deficits in measures of attention
and impulsivity. Studying the full range of adult age
between 18 and 65 also enabled us to test whether any
cognitive deficits would be moderated by age or be related
to cumulative exposure. A battery of established neuro-
psychological tests was used, covering memory,
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attention, language and impulsivity. Moreover, we
employed factor analysis of test scores in order to derive




The rationale and general methods of the German
multi-center study on smoking-related behavior have
been described elsewhere (Lindenberg et al. 2011). The
primary aim of the multi-center study is to identify genes
associated with smoking and different phenotypes asso-
ciated with smoking. Study participants were either
current smokers or never-smoking controls (maximum
20 cigarettes during lifetime). Former smokers were
excluded to minimize phenotypic heterogeneity. In order
to approach population representativeness, subjects were
randomly selected from the general population of seven
cities across Germany (Aachen, Berlin, Bonn, Düsseldorf,
Erlangen, Mainz and Mannheim) via official local resi-
dents’ registers. Subjects were contacted by letter with an
invitation to participate in the study. Across all seven
study centers, about 55 000 subjects were contacted, of
which about 10% responded by phone. When respond-
ing, an initial 10-minute pre-screening was conducted
by phone. Participants had to be of Western European
descent (all grandparents had to be born in Germany or
an adjacent country) to limit genotypic heterogeneity.
Only subjects who met inclusion/exclusion criteria (see
Table 1) were invited for a final screening, which was
based on a medical examination, a standardized psychi-
atric interview structured clinical interview for DSM-IV
disorders (SCID-1), a drug screen and carbon monoxide
(CO)Hb measurement. Based on the inclusion and exclu-
sion criteria, a total of 2396 subjects were enrolled in the
multi-center study. The present paper includes data from
2163 participants (1002 smokers and 1161 never-
smokers) with complete neuropsychological assessments.
With this sample size, deficits of small effect (0.2 SD), as
expected from the epidemiological literature, could be
detected with high statistical power (> 95%,
alpha < 0.01).
Study procedures
The study was approved by the ethics committees of each
study site’s local university and was conducted according
to the declaration of Helsinki. Written informed consent
was obtained from all subjects. Subjects were tested on
the day of study inclusion according to the same stan-
dard operating procedure (SOP) with strict adherence to
the same time schedule across all study sites. Repeated
on-site monitoring visits were conducted to ensure con-
formity with the SOP (see also Lindenberg et al. 2011).
After inclusion, study participants provided demo-
graphical and smoking-related information during an
interview. Lifetime nicotine consumption was estimated
by eliciting a detailed recall of individual smoking history,
including smoking onset and all times of abstinence, and
the average number of cigarettes for each continuous
period of smoking. Smokers smoked a cigarette of their
preferred brand before the 1-hour interview. The neuro-
psychological test battery was administered subsequently
(75-minute duration on average), typically at 10:15 AM
(begin of testing). Subsequently, an electroencephalo-
graphic (EEG) recording took place, followed by a stan-
dardized meal containing 600 kcal. Lastly, venous blood
was obtained between 2:00 PM and 4:30 PM to deter-
mine cotinine plasma levels and for the purpose of future
genotyping and metabolomic investigations. EEG and
endocrinological findings are published elsewhere (Mob-
ascher et al. 2010; Brinkmeyer et al. 2011; Koopmann
et al. 2011).
Cognitive testing
A comprehensive neuropsychological test battery was
administered to each subject by research assistants
trained and regularly supervised by a PhD-level
Table 1 Inclusion and exclusion criteria.
Inclusion criteria
Age: 18–65 years
Smoking status: current smoker (also occasional smoker
with a minimum of seven cigarettes per week/one cigarette
per day) or
Never-smoker (max. 20 cigarettes/lifetime)
Grandparents of probands were required to be born in
Germany or in a country adjacent to Germany.
Mother-tongue level German
Each proband must have been personally approached by
letter (via official local residents’ registers).
Exclusion criteria
Former smoker
Alcohol- or substance abuse within previous 6 months
(DSM-IV)
Alcohol- or substance dependence (DSM-IV)
Other DSM-IV axis-1 psychiatric diagnosis within previous 6
months
Non-German origin (see inclusion criteria)
No mother-tongue level German
Pregnancy
Any medical condition that may interfere with the study
CNS-relevant medication within previous 6 months
CNS-relevant (neurological) illnesses (lifetime)
CNS = central nervous system; DSM-IV = Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition.
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neuropsychologist Svenja Schulze-Rauschenbach (SSR).
The battery included the following tests, which were
administered in a fixed order as follows: continuous per-
formance test—identical-pairs-version (CPT-IP), audi-
tory verbal learning test (AVLT), learning and immediate
recall trials, trail-making test part A (TMT-A) and part B
(TMT-B), digit-span forward and backward subtests of
the Wechsler adult intelligence scale—revised (WAIS-R),
letter-number-sequencing (Gold et al. 1997 ), block span
forward and backward of the Wechsler memory scale—
revised (WMS-R), digit symbol substitution test (WAIS-
R), AVLT delayed recall and recognition trials, a Stroop
test, letter fluency (letters S, A, B and N; 1 minute each)
and a vocabulary test (MWT-B) involving lexical deci-
sions about words and pseudo-words, an established
German test of verbal intelligence. Total time for the neu-
ropsychological assessment did not exceed 90 minutes.
Cognitive testing was completed within 3 hours after the
last cigarette in order to minimize withdrawal-related
performance deficits.
Data reduction
We used a principal component analysis (PCA) with
varimax rotation to reduce the number of neuropsycho-
logical variables and to group variables empirically into a
limited set of distinct domains. This procedure for data
reduction requires no a priori assumptions on cognitive
domains and is particularly suitable for data sets of
studies with a large number of subjects. The reduced
number of cognitive variables also reduces the problem of
multiple testing.
Supplementary analyses were run with raw scores of
neuropsychological tests, which contributed to cognitive
factors differing between smokers and never-smokers.
Six cognitive factors
The PCA resulted in six readily interpretable factors
explaining 65.4% of the test score variance: verbal epi-
sodic memory (15.0% variance, consisting of the imme-
diate and delayed verbal memory scores of the AVLT),
visual attention (13.5% variance, containing block span
forward and backward, trail-making tests A and B
and digit-symbol-test), verbal fluency (13.2% variance),
verbal working memory (10.6% variance, comprising
digit-span forward and backward, letter-number-
sequencing and CPT-IP: d-prime), impulsivity [6.7% vari-
ance, consisting of two continuous performance task
(CPT) variables, fast reaction times for hits and a more
liberal response criterion logBeta, together reflecting a
speed-accuracy trade-off] and interference (6.4%, two
Stroop task variables, response slowing by interference
and errors during the interference trial). This empi-
rical grouping by the PCA is largely consistent with
neuropsychological conventions. However, note that
visual attention and verbal working memory were sepa-
rated by the PCA, despite the fact that both factors
contain apparently similar span tasks (spatial span and
digit span, respectively). Possibly as a result of this split,
the sensitivity measure ‘d’ of the CPT-IP loaded on both
the visual attention and the verbal working memory
factor, but with low factor loadings. This may come from
the fact that the four-number stimuli of the CPT can be
encoded both verbally and as figural patterns, and people
may differ with regard to their strategy. Table 2 provides
an overview of the six cognitive factors resulting from the
PCA and specifies which test variables were employed for
each cognitive test. Table 3 depicts the PCA factor load-
ings of the cognitive test scores.
Statistical analysis
To investigate the effect of smoking status on cognition,
separate univariate general linear model analyses with
each of the six cognitive domain scores as the dependent
variable were calculated. Unsurprisingly, all cognitive
factor scores were significantly correlated with age or
with years of school education (this was most pro-
nounced for factor 2, visual attention), orwere affected by
gender (this was most pronounced for factor 1, verbal
memory). We took this into account by including gender
as a between-subjects factor and age and school educa-
tion as covariates in the analyses of variance. We also
included study site as an additional factor in order to
control for possible differences between assessment sites
and to examine the homogeneity of differences between
smokers and never-smokers across sites. The interaction
between the smoker/never-smoker group difference and
site was not significant for any of the cognitive variables,
which shows that these group differences were homo-
genous across sites. For significant group effects, we
calculated effect sizes (Cohen’s d) from the age- and
education-adjusted means and standard errors, to
provide a commonly used metric for the level of impair-
ment. All statistical analyses were performed using the
Statistical Package for the Social Sciences (SPSS) 18 soft-
ware package (SPSS Inc. Chicago, IL, USA).
RESULTS
Socio-demographic and smoking-related data
Socio-demographic and smoking-related data are pro-
vided in Table 4. Urine drug screens were negative in all
study participants. All probands performed the alcohol
use disorder identification test (AUDIT; Saunders et al.
1993). Smokers had higher AUDIT scores than never-
smokers (P < 0.001).
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Smokers were divided in two subgroups based on the
Fagerstrom test for nicotine dependence (FTND). As in
previous studies (Heatherton et al. 1991), subjects with a
FTND  4 were considered smokers with moderate to
high degree of nicotine dependence (e.g. Bierut et al.
2008; Agrawal et al. 2009). Smokers with a FTND < 4
were considered ‘light’ smokers with no or minimal nico-
tine dependence.
Cognition in smokers and never-smokers
As summarized in Table 5, smokers did not differ from
never-smokers with regard to verbal memory, verbal
fluency, verbal working memory or interference in the
Stroop task. However, small but highly significant deficits
were detected with tasks assessing visual attention
(d = 0.25, P < 0.001) and impulsivity (d = 0.15, P =
0.0014; see also Fig. 1). These effects were all indepen-
dent of gender, and were thus observable both in female
and male smokers.
Significant performance deficits in smokers were
found for each single test contributing either to the visual
attention factor (spatial span, P < 0.001, trail-making
test A, P = 0.003, trail-making test B, P = 0.012, digit
symbol substitution test, P < 0.001) or to the impulsivity
factor (CPT log beta, P = 0.003; CPT reaction time for
hits, P = 0.014).
Further analyses compared all never-smokers with
either light smokers (FTND < 4, n = 546) or with heavy
smokers (FTND > = 4, n = 427), and both groups of
smokers with each other. This revealed small, but signifi-
cant deficits in light smokers for visual attention
(P < 0.001, d = 0.25) and impulsivity (P = 0.005,
d = 0.13), and very similar deficits in strong smokers, as
compared with never-smokers (visual attention P <
0.001, d = 0.26, impulsivity P = 0.082, d = 0.16). Light
and strong smokers did not differ from each other with
regard to any of the cognitive factors (P > 0.5). Partial
correlations, controlling for age and education, between
cognitive factor scores and either the FTND or the
number of cigarettes smoked daily were very small
(partial | r | < 0.05) and insignificant (P > 0.1).
The role of ADHD symptoms
Smokers reportedmore attention deficit hyperactivity dis-
order (ADHD) symptoms than never-smokers (smokers,
7.1  5.54; never-smokers, 1.06  4.23, P < 0.001).
We examined whether the group differences regarding
the neuropsychological factors attention and impulsivity
Table 2 Cognitive factors derived from the neuropsychological test battery.
Cognitive factor Cognitive test Test variables Reference
F1: Verbal episodic memory
Auditory verbal learning test (AVLT) Number correct trial 1
(immediate recall)
Helmstaedter et al. 2001
Number correct trials 1–5




Block span forward/backward (WAIS-R) Sumscore correct answers Tewes 1991
Trail-making test—part A (TMT-A) Time (s) Reitan 1979
Trail-making test—part B (TMT-B) Time (s) Reitan 1979
Digit symbol test (WAIS-R) Number correct Tewes 1991
F3: Verbal fluency
Letter fluency (letters S, A, B, N;
1 minute each)
Number correct
F4: Verbal working memory
Digit-span forward/backward (WAIS-R) Sumscore correct answers Tewes 1991
Letter-number-sequencing (BZT) Sumscore correct answers Gold et al. 1997
Continuous performance test (CPT-IP) Deprime score (numbers and shapes) Cornblatt et al. 1988
F5: Impulsivity
Continuous performance test (CPT-IP) Reaction time for hits Cornblatt et al. 1988
Log beta (errors)
F6: Interference
Stroop test Errors during color-word interference Stroop 1935; Bäumler
1985
Stroop test Slowing (difference) by interference Stroop 1935; Bäumler
1985
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might be mediated by a higher level of self-reported
ADHD symptoms in smokers, or might be explained by a
higher proportion of subjects withADHD. BecauseADHD
symptoms are considered to be continuous traits, and
because the prevalence of adult ADHD is estimated to be
4–5%, we defined the 95th percentile in the ADHD
symptom list as a cut-off to define cases.
When the number of ADHD symptoms was included
as an additional covariate, the cognitive differences
between smokers and never-smokers remained
significant (visual attention, P < 0.001; impulsivity,
P = 0.001). Likewise, excluding subjects scoring above
the 95th percentile in the ADHD symptom list did not
alter the group differences.
Table 3 A principal component analysis of cognitive test scores with varimax rotation resulted in six readily interpretable factors
explaining 65.4% of the test score variance: verbal episodic memory (factor 1), visual attention (factor 2), verbal fluency (factor 3),
verbal working memory (factor 4), impulsivity (factor 5) and interference (factor 6).
Loadings on factor no.
Com Scale1 2 3 4 5 6
0.90 — — — — — 0.65 AVLT trial 7 (recall after delay)
0.89 — — — — — 0.45 AVLT trial 6 (recall after interference)
0.81 — — — — — 0.60 AVLT trials 1–5
0.73 — — — — — 0.72 AVLT recognition (hits minus false alarms)
— 0.72 — — — — 0.58 Block span backward
— -0.69 — — — — 0.55 Trail-making test A
— 0.67 — — — — 0.64 Block span forward
— -0.67 — — — — 0.66 Trail-making test B
0.31 0.63 — — — — 0.78 Digit symbol test
— — 0.81 — — — 0.86 Letter fluency S
— — 0.80 — — — 0.87 Letter fluency A
— — 0.79 — — — 0.55 Letter fluency B
— — 0.77 — — — 0.69 Letter fluency N
— — — 0.81 — — 0.69 Digit-span forward
— — — 0.77 — — 0.53 Digit-span backward
— — — 0.71 — — 0.59 Letter-number-sequencing
— 0.32 — 0.44 -0.31 — 0.65 CPT d-prime
— — — — 0.80 — 0.66 CPT reaction time
— — — — 0.76 — 0.67 CPT log beta
— — — — — 0.83 0.69 Stroop task errors (interference trial)
— -0.33 — — — -0.64 0.65 Stroop task time (interference trial minus time
color naming trial)
3.2 2.8 2.8 2.2 1.4 1.3 Eigenvalues of rotated factors
15.0 13.5 13.2 10.6 6.7 6.4 % of variance explained (total: 65,4%)
AVLT, auditory verbal learning test; CPT, continuous performance test.






(n = 1161) P
Age in years (SD) 35.0 (12.8) 36.1 (12.5) 34.0 (13.0) < 0.001
% females 57.8 54.7 60.5 0.007
Years of school education (SD) 11.8 (1.5) 11.4 (1.6) 12.1 (1.4) < 0.001
Exhaled CO in parts per million (SD) 7.1 (9.6) 13.4 (11.0) 1.7 (1.6) < 0.001
FTND (SD)a – 3.07 (2.61) – –
Cigarettes per day (SD)a – 14.0 (10.0) – –
Age of onset (years) (SD)a – 16.2 (3.4) – –
Pack years (SD)a – 13.2 (12.7) – –
Cigarettes per life time (SD))b – – 6.0 (9.8) –
AUDIT (SD) 4.0 (3.3) 4.9 (3.7) 3.2 (2.7) < 0.001
aOnly obtained in smokers (corrected for periods of abstinence). bOnly obtained in never-smokers. AUDIT = Alcohol use disorders identification test;
FTND = Fagerstrom test for nicotine dependence; SD = standard deviation.
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The role of alcohol consumption
Alcohol use, assessed with the AUDIT, was more pro-
nounced in smokers (P < 0.001). However, inclusion of
the AUDIT score as a covariate did not alter the cognitive
differences between smokers and never-smokers (visual
attention, P < 0.001; impulsivity, P = 0.001).
Age and lifetime nicotine consumption
Prospective studies suggest that smoking may be related
to cognitive decline, and particularly memory decline, in
the elderly (Anstey et al. 2007), and possibly also in
middle-aged subjects (Richards et al. 2003). To examine
whether cognitive impairments were more pronounced
in the elderly smokers of our sample, we repeated the
regression analyses for the factors with significant group
differences (factor 2, visual attention; factor 5, cognitive
impulsivity) and for factor 1 (memory), adding the inter-
action term age x group (smoker/non-smoker) to the
model. This term was not significant in any of these
analyses.
Partial correlations, controlling for age and educa-
tion, between cognitive factor scores and the estimated
number of pack-years were small (partial | r | < 0.05)
and insignificant (P > 0.1).
DISCUSSION
The present study clearly demonstrates modest and
domain-specific cognitive impairments in smokers as
Table 5 Cognitive group differences between smokers and never-smokers: estimated cognitive factor means (adjusted for age and
education).
Never-smokers Smokers F(1, 2126) P
Effect size
(Cohen’s d)
Factor 1: verbal episodic memory -0.018 -0.027 0.01 0.98
Factor 2: visual attention 0.100 -0.143 32.31 0.000000015 0.25
Factor 3: verbal fluency -0.048 -0.014 0.52 0.47
Factor 4: verbal working memory 0.011 0.057 0.95 0.33
Factor 5: CPT impulsivity -0.027 0.129 10.23 0.0014 0.15
Factor 6: Stroop interference -0.051 -0.019 0.42 0.52

































Figure 1 Cognitive factor scores (means and 95% confidence intervals) for non-smokers (open diamonds) and smokers (filled diamonds),
adjusted for age and education
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compared with never-smokers in a large population-
based sample of adult, psychiatrically healthy subjects.
Consistent deficits were found in several tests contribut-
ing to the visual attention domain score (factor 2),
including both speeded and non-speeded attention and
working memory tasks. Smokers also had a more liberal
response criterion and had faster reactions during the
CPT-IP (factor 5), suggestive of an increased cognitive
impulsivity in smokers in a task tapping also into visual
sustained attention and working memory. There were no
significant group differences in any other cognitive
domain. In particular, no group differences were found
for the verbal span tasks (digits forward, digits backward),
which are formally quite similar to spatial span (blocks
forward, blocks backward). Thus, our results suggest that
visual attention may be selectively impaired in smokers.
The pattern of findings in the present study are largely
in line with the results by Yakir et al. (2007), who inves-
tigated the neurocognitive profile of female college stu-
dents in a sample composed of current smokers, past
smokers and non-smokers. They found that current
smokers were impaired on tests of sustained attention
and control of impulsivity, i.e. current smokers made sig-
nificantly more errors than non-smokers on the CPT,
matching familiar figures test (MFFT) and tower of
London (TOL) test. Moreover, past smokers were signifi-
cantly worse than non-smokers on the MFFT and TOL
test and past smokers did not significantly differ from
current smokers on any test (Yakir et al. 2007). These
findings comparing past and current smokers suggest
that impairments in sustained attention and control of
impulsivity may be present before the onset of smoking
and they might be predisposing factors for the initiation
and maintenance of smoking habits. In addition, they
found no association between duration of smoking and
cognitive performance—this argues against the idea that
primarily lifetime accumulated nicotine or tobacco toxic-
ity accounts for cognitive impairments in smokers. Our
data also speak in favor of an a priori attention/
impulsivity endophenotype in smokers, as neither visual
attention nor impulsivity was related to the estimated
lifetime cigarette dose (pack-years, corrected for periods
of abstinence) after controlling for age and education in
our study. Given the broad age distribution, the large
sample size and the detailed assessment of smoking
history, the power of the present study to find such asso-
ciations was high. However, we did not find evidence for
an adverse effect of smoking history or of smoking inten-
sity on cognition in adults aged 18–65. Neither did we
find that cognitive differences between smokers and non-
smokers increased with age in our sample.
This does not imply that nicotine does not confer risks
for cognitive health, but rather suggests that these risks
may become evident only in more advanced age, and are
possibly mediated by vascular lesions or by other
smoking-related health hazards (Crevilla, Prince & Mann
2000; Hill et al. 2003; Mitchell 2004).
While the statistical significance of the attention
deficit and of the increased impulsivity is high in our
sample, the effect sizes are only small for the group of
smokers as awhole. Are the effects stronger for subgroups
of smokers, e.g. for dependent smokers, or for subjects
reporting a large number of symptoms suggestive of
ADHD? Surprisingly, the attentional deficits in smokers
were independent from the level of nicotine dependence
as well as from the number of ADHD symptoms.
This specific visual attention deficit emerged in analy-
ses that adjusted statistically for formal education, which
was significantly lower in smokers as comparedwith non-
smokers. Such adjustments have also been used in prior
large-scale studies on cognition in smokers (Cerhan et al.
1998; Sabia et al. 2008) and aim at controlling for group
differences considered as irrelevant (e.g. differences
resulting from participation bias). However, some evi-
dence suggests that lower intelligence and lower formal
education in childhood and adolescence is associated
with an increased risk of smoking in adulthood (Kubicka
et al. 2001;Weiser et al. 2010).We also found smokers to
have slightly lower verbal intelligence. Including educa-
tion or intelligence quotient (IQ) as covariates probably
attenuates the ‘genuine’ dispositional cognitive differ-
ences between smokers and non-smokers. Consequently
both, specific cognitive measures of visual attention and
impulsivity, as well as global measures of cognitive func-
tion like IQ or formal education, should be examined as
cognitive phenotypes in future studies on the genetics of
smoking.
Several lines of evidencemake it very unlikely that the
attention deficits in chronic smokers were short-term
nicotine withdrawal effects. We monitored subjects
during smoking before they entered the testing protocol
of this study. Cognitive testing began about 1 hour after
the last cigarette and was completed after 3 hours in all
cases. The half-life of nicotine is 100–150 minutes, and
withdrawal effects are therefore expected only after about
3 or more hours of abstinence (Yakir et al. 2007). In line
with this, subjective early withdrawal effects, like nega-
tive mood, smoking urges and subjective difficulty con-
centrating tend to appear 3–4 hours after the last
cigarette (Parrott et al. 1996). Research with objective
measures has shown slower reaction times, but not
reduced accuracy, in some attentional measures, already
in the first 4 hours after the last cigarette (Snyder, Davis &
Henningfield 1989; Parrott et al. 1996; Hendricks et al.
2006). However, we did find faster, rather than slower
response times in smokers in the CPT-IP, and group dif-
ferences were found both for accuracy and speeded mea-
sures of visual attention. In addition, studies putatively
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showing early withdrawal effects on objective measures
are inconclusive, because they compare ad libitum or
regular smoking during testing with short-term absti-
nence. Because of the acute cognitive enhancement
effects of nicotine, which occurs even in non-deprived
smokers (Heishman et al. 2010), this design cannot dis-
tinguish the offset of an acute cognitive enhancement
effect of nicotine from a possible withdrawal effect early
after the last cigarette. We conclude that the deficits mea-
sured between 1 and 3 hours in smokers are very likely
genuine trait differences and are not due to an early with-
drawal state.
Given the effect size of acute enhancement effects
on several performance domains (0.16–0.44 SD,
according to the meta-analysis by Heishman et al.
(2010), and the effect size of deficits described here and
in the epidemiological literature in non-deprived
smokers (0.15-0.25) SD, it may well be that immediately
after smoking a cigarette, smokers for a short while
perform at a level, or even better, than non-smokers.
Thus, smoking can be seen as a kind of self-medication
for subtle attentional impairments even in the absence
of co-morbid psychiatric conditions (Swan & Lessov-
Schlaggar 2007).
In summary, replicating and extending prior data, our
results show small, but highly specific visual attentional
deficits in non-deprived male and female smokers drawn
from the general population. These deficits cannot be
attributed to the amount of cigarettes smoked during life-
time or to acute withdrawal effects, and may thus be part
of the constitutional vulnerability for the initiation and
maintenance of smoking. We will continue to explore
which genetic variants associated with smoking may be
related with the cognitive endophenotypes delineated
herein.
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